Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jianpi Huoxue Recipe for Gastric Premalignant Lesion
NCT03823248Phase 2Unknown
- Sponsor
- Xiyuan Hospital
- Start
- Mar 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of moluodan and sanqi tongshu in Gastric precancerous lesions (GPL) (2 arms), sponsored by Xiyuan Hospital. Primary endpoints: The disappearance rate of dysplasia at 6 months and The score changes of histopathology at 6 months. Status: unknown.
02
Drugs
moluodansanqi tongshu
03
Conditions
Gastric precancerous lesions (GPL)
Beyond the preview
Go deeper on NCT03823248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03823248.